Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome

Trial Profile

Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs Liraglutide (Primary) ; Metformin
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jun 2017 Primary endpoint of change in body weight has not been met, according to results presented at the 77th Annual Scientific Sessions of the American Diabetes Association.
    • 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top